Synlife is innovating new therapeutic and diagnostic platforms through bottom-up engineering of synthetic cells.The company's platform builds synthetic minimal cells bottom-up that contain a biochemical mix of proteins which can transcribe and translate genes and a DNA program, enabling medical researchers to detect low abundance molecular